Lupin launches generic Niaspan in US
The tablets are used for reducing cholesterol.
New Delhi, March 25, 2014: Indian drug firm Lupin Ltd has launched its generic version of the Niaspan extended release tablets in the US market. The tablets are used for reducing cholesterol.
It may be noted here that these tablets are generic equivalent of AbbVie Inc's Niaspan tablets.
The company believes that the approval for this product from USFDA bears testimony to its commitment to serving the customers and patients by bringing high quality, affordable medicines to the market.
According to the IMS Health data, the Niaspan tablets had annual sales worth US$ 1 billion in the US in 2013.
Niaspan tablets are used with diet to lower bad cholesterol while increasing the levels of good cholesterol in the body.